Micronized dHACM Injectable for the Treatment of Achille Tendonitis

PHASE3CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Tendonitis;Achilles
Interventions
BIOLOGICAL

Micronized DHACM

1 mL injection of 40mg Micronized dehydrated human amnion/chorion membrane (DHACM).

DRUG

Saline Injection

Injection of 1mL 0.9% Sodium Chloride Injection, USP

Trial Locations (14)

15224

West Penn Hospital, Pittsburgh

16602

University Orthopedics Center, Altoona

23464

Coastal Podiatry, Inc., Virginia Beach

30518

Northside Podiatry, Buford

33125

South Florida Veterans Affairs, Miami

33143

Doctors Research Network, Miami

35205

Central Research Associates, Birmingham

62704

Foot and Ankle Center of Illinois, Springfield

78501

Futuro Clinical Trials, McAllen

85723

Southern Arizona VA Health Care System, Tucson

89119

Advanced Foot & Ankle Center, Las Vegas

90057

Foot and Ankle Clinic, Los Angeles

92009

ILD Research Center, Carlsbad

93449

Five Cities Foot Clinic, Pismo Beach

All Listed Sponsors
lead

MiMedx Group, Inc.

INDUSTRY

NCT03414255 - Micronized dHACM Injectable for the Treatment of Achille Tendonitis | Biotech Hunter | Biotech Hunter